跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LONQUEX lipegfilgrastim (rbe) 6 mg/0.6 mL solution for injection prefilled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
LONQUEX lipegfilgrastim (rbe) 6 mg/0.6 mL solution for injection prefilled syringe
Approved
STANDARD
LONQUEX lipegfilgrastim (rbe) 6 mg/0.6 mL solution for injection prefilled syringe
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b113ad901cf0f2b6
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
b113ad901cf0f2b6
Product Name
LONQUEX lipegfilgrastim (rbe) 6 mg/0.6 mL solution for injection prefilled syringe
Artg Id
231016
Artg Name
LONQUEX lipegfilgrastim (rbe) 6 mg/0.6 mL solution for injection prefilled syringe
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2015-11-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-02230-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-02870-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b113ad901cf0f2b6
Type
Standard
Back to TGA Approvals